Oral Wegovy vs Wegovy Injection: What Is Different?

If you're comparing the Wegovy pill with the Wegovy injection, the biggest difference isn't simply "pill versus shot." Both contain semaglutide, but they're absorbed differently, come in different strengths and fit into very different daily routines. This guide reflects the US label as of October 2026; the current official label is the source of truth because approved uses and instructions can change.

The basics

• Wegovy injection: once a week, under the skin of the stomach, thigh or upper arm, any time of day, with or without food. It starts at 0.25 mg and steps up every 4 weeks, usually to a 2.4 mg maintenance dose. A higher 7.2 mg dose (Wegovy HD) was approved in March 2026 for some adults.
• Wegovy tablets: approved by the FDA in December 2025. One tablet daily, starting at 1.5 mg and stepping up every 30 days to a 25 mg maintenance dose.

Why the pill has rules

Oral semaglutide is fussy about how it's taken because food and drink cut how much gets absorbed. The label says to take the tablet in the morning on an empty stomach with up to 4 ounces (about half a cup) of plain water, swallow it whole, and then wait at least 30 minutes before eating, drinking anything else or taking other oral medicines.

That's also why tablet milligrams can't be compared with injection milligrams. A 25 mg tablet isn't "ten times stronger" than a 2.4 mg shot. In people without type 2 diabetes, the label says average blood levels from the 25 mg tablet are similar to the 2.4 mg injection, but they vary more from person to person. In people with type 2 diabetes, blood levels from the tablet were lower on average.

What each is approved for

Both forms are approved in the US for long-term weight reduction in adults with obesity, or overweight plus at least one weight-related condition, and for lowering the risk of major cardiovascular events in adults with established heart disease and obesity or overweight. Only the injection is approved for teens aged 12 and up and for MASH (a type of fatty liver disease with fibrosis). Approval and availability differ by country.

What about results and side effects?

The tablet's main trial followed 307 adults with obesity or overweight (without diabetes) for 64 weeks. Average weight change was −13.6% with the 25 mg tablet versus −2.4% with placebo. That's in the same general range as the original 2.4 mg injection trials, but these were separate studies with different people and lengths, so they aren't a head-to-head comparison.

Both forms commonly cause digestive side effects like nausea, diarrhea, vomiting and constipation, and they share the same warnings, including the boxed warning about thyroid C-cell tumors. Some people on either form report unusual skin sensations such as tingling or burning; in the tablet trial this was reported by 5% of people on the tablet and none on placebo. Our semaglutide side-effects guide covers what's common and what's serious.

Convenience is personal

A pill may appeal to someone who'd rather avoid needles. Someone else may prefer one weekly shot to a daily morning routine with a 30-minute wait. If you take several other morning medicines, the timing rules matter too. Cost, insurance coverage and availability also play a big part. Neither form is best for everyone.

Questions before deciding

Ask which form is approved where you live for your goal, how it has to be taken, how it fits with your other medicines, what to do if you miss a dose, and how your response will be judged. The label does describe how to switch between the injection and tablets, but switching is a decision to make with your prescriber, not by translating one form's dose into the other yourself.

The practical takeaway: oral and injectable Wegovy share an active ingredient, but they aren't interchangeable routines. Compare the exact products and labels, not just the way they're taken. For how these fit among the other new options, see the new weight-loss medicines of 2026.